Apotex Inc. has announced the appointment of Peter Hardwick as president and CEO of the Canadian generics giant’s US Apotex Corp unit, effective immediately. Most recently, Hardwick has served in an interim leadership role at Apotex Corp, “helping to navigate the business through unprecedented challenges created by the pandemic,” having been with Apotex for 14 years.
Jeff Watson, global president and CEO of Apotex commented that Hardwick’s “track record as a commercial executive in the pharmaceutical...




